AFORÉ™ BY DR. FEW ANNOUNCES PUBLICATION OF THE FIRST-EVER STUDY EVALUATING THE EFFECTS OF RETINOL AND CANNABIDIOL (CBD) IN TOPICAL SKINCARE

Aforé™ by Dr. Few, a clinically developed skincare line built around Dr. Julius Few’s innovative Four Dimensional Beauty™ philosophy, today announces the publication of the first-ever clinical study on the effects of a retinol and Cannabidiol (CBD) combination in topical skincare by the Aesthetic Surgery Journal.